SHENZHEN, China, March 11 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its subsidiary Mellow Hope announce that the company received Registration Certificate for its MEVAC-Vari vaccine in Guatemala. This is the first Final Approval for HTDS' Varicella vaccine in South America.

SHENZHEN, China, Nov. 30 /PRNewswire-FirstCall/ - Hard to Treat Diseases' (HTDS; http://www.htdsmedical.com/) operating subsidiary Mellow Hope finalized contract details with one of the largest manufacturer of intravenous medication in India.

SHENZHEN, China, Aug. 31 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS.PK) www.htdsmedical.com - is pleased to announce today that Mellow Hope, an operating subsidiary of HTDS, is providing another government tender. This one is for 50,000 doses of Mevac A in Sri Lanka.

SHENZHEN, China, Aug. 11 /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc. (HTDS:PK), (http://www.htdsmedical.com) subsidiary, Shenzhen Mellow Hope Pharm Industrial Co., Ltd.

SHENZHEN, China, Aug. 7 /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc. (HTDS:PK), (http://www.htdsmedical.com) subsidiary, Shenzhen Mellow Hope Pharm Industrial Co., Ltd.